ADGC Publications

Found 61 results
Filters: Keyword is Aged, 80 and over  [Clear All Filters]
2012
Majounie E, Renton AE, Mok K, Dopper EGP, Waite A, Rollinson S, Chiò A, Restagno G, Nicolaou N, Simon-Sanchez J et al..  2012.  Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.. Lancet Neurol. 11(4):323-30.
Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA et al..  2012.  GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.. Neurology. 79(19):1944-50.
Barral S, Bird T, Goate A, Farlow MR, Diaz-Arrastia R, Bennett DA, Graff-Radford N, Boeve BF, Sweet RA, Stern Y et al..  2012.  Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.. Neurology. 78(19):1464-71.
Vardarajan BN, Bruesegem SY, Harbour ME, Inzelberg R, Friedland R, St George-Hyslop P, Seaman MNJ, Farrer LA.  2012.  Identification of Alzheimer disease-associated variants in genes that regulate retromer function.. Neurobiol Aging. 33(9):2231.e15-2231.e30.
2011
Bekris LM, Galloway NM, Millard S, Lockhart D, Li G, Galasko DR, Farlow MR, Clark CM, Quinn JF, Kaye JA et al..  2011.  Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.. Neurobiol Aging. 32(3):556.e13-23.
Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan BNarayan, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al..  2011.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
2010
Li G, Shofer JB, Rhew IC, Kukull WA, Peskind ER, McCormick W, Bowen JD, Schellenberg GD, Crane PK, Breitner JCS et al..  2010.  Age-varying association between statin use and incident Alzheimer's disease.. J Am Geriatr Soc. 58(7):1311-7.
Bekris LM, Galloway NM, Montine TJ, Schellenberg GD, Yu C-E.  2010.  APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure.. Am J Med Genet B Neuropsychiatr Genet. 153B(2):409-417.
Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES et al..  2010.  A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.. Neurology. 75(13):1189-94.
Marchani EE, Bird TD, Steinbart EJ, Rosenthal E, Yu C-E, Schellenberg GD, Wijsman EM.  2010.  Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families.. Am J Med Genet B Neuropsychiatr Genet. 153B(5):1031-41.
Jun G, Naj AC, Beecham GW, Wang L-S, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, M Fallin D, Friedland R et al..  2010.  Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.. Arch Neurol. 67(12):1473-84.

Pages